Evidence map›Paper›PMID 32444853›Full record

ArticleNature biotechnology2020

Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.

Annabelle Gérard, Adam Woolfe, Guillaume Mottet, Marcel Reichen, Carlos Castrillon, Vera Menrath, Sami Ellouze, Adeline Poitou, Raphaël Doineau, Luis Briseno-Roa and 27 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Multi-omics in exploring the pathophysiology of diabetic retinopathy.Frontiers in cell and developmental biology · 2024
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Annabelle GérardHiFiBiO Therapeutics SAS, Paris, France.ORCID http://orcid.org/0000-0003-0411-768X
Adam Woolfe *HiFiBiO Therapeutics SAS, Paris, France.
Guillaume Mottet *Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
Marcel Reichen *HiFiBiO Therapeutics SAS, Paris, France.
Carlos Castrillon *Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.ORCID http://orcid.org/0000-0003-2909-7371
Vera Menrath *HiFiBiO Therapeutics SAS, Paris, France.
Sami Ellouze *HiFiBiO Therapeutics SAS, Paris, France.
Adeline Poitou *HiFiBiO Therapeutics SAS, Paris, France.
Raphaël Doineau *HiFiBiO Therapeutics SAS, Paris, France.ORCID http://orcid.org/0000-0003-0817-7778
Luis Briseno-RoaHiFiBiO Therapeutics SAS, Paris, France.
Pablo Canales-HerreriasUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.ORCID http://orcid.org/0000-0002-1865-6476
Pascaline MaryHiFiBiO Therapeutics Inc., Cambridge, MA, USA.
Gregory RoseHiFiBiO Therapeutics Inc., Cambridge, MA, USA.
Charina OrtegaHiFiBiO Therapeutics Inc., Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8814-8629
Matthieu DelincéHiFiBiO Therapeutics Inc., Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-8052-7918
Sosthene EssonoHiFiBiO Therapeutics Inc., Cambridge, MA, USA.
Bin JiaPfizer, Cambridge, MA, USA.
Bruno IannascoliUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
Odile Richard-Le GoffUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
Roshan KumarHiFiBiO Therapeutics Inc., Cambridge, MA, USA.
Samantha N StewartHiFiBiO Therapeutics Inc., Cambridge, MA, USA.
Yannick PousseHiFiBiO Therapeutics SAS, Paris, France.
Bingqing ShenHiFiBiO Therapeutics SAS, Paris, France.
Kevin GrosselinHiFiBiO Therapeutics SAS, Paris, France.
Baptiste SaudemontUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
Antoine Sautel-CailléLaboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.ORCID http://orcid.org/0000-0003-3899-3020
Alexei GodinaLaboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
Scott McNamaraHiFiBiO Therapeutics SAS, Paris, France.
Klaus EyerLaboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.ORCID http://orcid.org/0000-0001-9344-5110
Gaël A MillotInstitut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.ORCID http://orcid.org/0000-0002-0591-3509
Jean BaudryLaboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.ORCID http://orcid.org/0000-0002-5526-499X
Patrick EnglandPlateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.
Clément NizakLaboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.ORCID http://orcid.org/0000-0002-4591-8240
Allan JensenHiFiBiO Therapeutics SAS, Paris, France.
Andrew D GriffithsLaboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr.ORCID http://orcid.org/0000-0002-0808-3539
Pierre BruhnsUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr.ORCID http://orcid.org/0000-0002-4709-8936
Colin BrenanHiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.ORCID http://orcid.org/0000-0002-9570-6166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32444853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.